An RNA element in human interleukin 6 confers escape from degradation by the Gammaherpesvirus SOX protein

Journal of Virology

Volumn 87, Issue 8, 2013, Pages 4672-4682

  Hutin, Stephanie ^a   Lee, Yeon ^a,b   Glaunsinger, Britt ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HUR PROTEIN; INTERLEUKIN 6; SOX PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; AU RICH ELEMENT; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION; INTERLEUKIN 6 GENE; KAPOSI SARCOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REGULATORY RNA SEQUENCE;

B-LYMPHOCYTES; CELLS, CULTURED; ENDONUCLEASES; HERPESVIRUS 8, HUMAN; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HOST-PATHOGEN INTERACTIONS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; INTERLEUKIN-6; PROTEIN BINDING; RNA STABILITY; RNA, MESSENGER; VIRAL PROTEINS;

HUMAN HERPESVIRUS 8;

EID: 84875791334     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00159-13     Document Type: Article

References (55)

1. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120:939-949.
2. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi"s sarcoma. Annu. Rev. Pathol. 1:273-296.
3. Glaunsinger B, Ganem D. 2004. Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 13:713-723.
4. Covarrubias S, Gaglia MM, Kumar GR, Wong W, Jackson AO, Glaunsinger BA. 2011. Coordinated destruction of cellular messages in translation complexes by the gammaherpesvirus host shutoff factor and the mammalian exonuclease Xrn1. PLoS Pathog. 7:e1002339. doi:10.1371 /journal.ppat.1002339.
5. Richner JM, Clyde K, Pezda AC, Cheng BY, Wang T, Kumar GR, Covarrubias S, Coscoy L, Glaunsinger B. 2011. Global mRNA degradation during lytic gammaherpesvirus infection contributes to establishment of viral latency. PLoS Pathog. 7:e1002150. doi:10.1371/journal.ppat .1002150.
6. Glaunsinger B, Ganem D. 2004. Highly selective escape from KSHVmediated hostmRNAshutoff and its implications for viral pathogenesis. J. Exp. Med. 200:391-398.
7. Chandriani S, Ganem D. 2007. Host transcript accumulation during lytic KSHV infection reveals several classes of host responses. PLoS One 2:e811. doi:10.1371/journal.pone.0000811.
8. Aoki Y, Yarchoan R, Braun J, Iwamoto A, Tosato G. 2000. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 96:1599-1601.
9. Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G. 1999. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi"s sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94:2871-2879.
10. Oksenhendler E, Carcelain G, Aoki Y, Boulanger E, Maillard A, Clauvel JP, Agbalika F. 2000. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96:2069-2073.
11. Drexler HG, Meyer C, Gaidano G, Carbone A. 1999. Constitutive cytokine production by primary effusion (body cavity-based) lymphomaderived cell lines. Leukemia 13:634-640.
12. Cirone M, Lucania G, Aleandri S, Borgia G, Trivedi P, Cuomo L, Frati L, Faggioni A. 2008. Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells. Immunol. Lett. 120:37-41.
13. Huang SP, Wu MS, Shun CT, Wang HP, Lin MT, Kuo ML, Lin JT. 2004. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J. Biomed. Sci. 11:517-527.
14. Jee S.H Chu CY, Chiu HC, Huang YL, Tsai WL, Liao YH, Kuo ML. 2004. Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/ Akt pathways. J. Investig. Dermatol. 123:1169-1175.
15. Deng .H Chu JT, Rettig MB, Martinez-Maza O, Sun R. 2002. Rta of the human herpesvirus 8/Kaposi sarcoma-associated herpesvirus upregulates human interleukin-6 gene expression. Blood 100:1919-1921.
16. McCormick C, Ganem D. 2005. The kaposin B protein ofKSHVactivates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307:739-741.
17. Xie J, Pan H, Yoo S, Gao SJ. 2005. Kaposi"s sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways. J. Virol. 79:15027-15037.
18. An J, Lichtenstein AK, Brent G, Rettig MB. 2002. The Kaposi sarcomaassociated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood 99:649-654.
19. Nakamura .H Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU. 2003. Global changes in Kaposi"s sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 77:4205-4220.
20. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J. Virol. Methods 174:12-21.
21. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45.
22. Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA. 2010. Sequence-and structure-specific RNA processing by a CRISPR endonuclease. Science 329:1355-1358.
23. Suzuki K, Bose P, Leong-Quong RY, Fujita DJ, Riabowol K. 2010. REAP: a two minute cell fractionation method. BMC Res. Notes 3:294.
24. Paschoud S, Dogar AM, Kuntz C, Grisoni-Neupert B, Richman L, Kühn LC. 2006. Destabilization of interleukin-6mRNArequires a putative RNA stem-loop structure, an AU-rich element, and the RNA-binding protein AUF1. Mol. Cell. Biol. 26:8228-8241.
25. Dhamija S, Kuehne N, Winzen R, Doerrie A, Dittrich-Breiholz O, Thakur BK, Kracht M, Holtmann H. 2011. Interleukin-1 activates synthesis of interleukin-6 by interfering with a KH-type splicing regulatory protein (KSRP)-dependent translational silencing mechanism. J. Biol. Chem. 286:33279-33288.
26. Palanisamy V, Jakymiw A, Van Tubergen EA, D'Silva NJ, Kirkwood KL. 2012. Control of cytokine mRNA expression by RNA-binding proteins and microRNAs. J. Dent. Res. 91:651-658.
27. Zhao W, Liu M, D'Silva NJ, Kirkwood KL. 2011. Tristetraprolin regulates interleukin-6 expression through p38 MAPK-dependent affinity changes with mRNA 3= untranslated region. J. Interferon Cytokine Res. 31:629-637.
28. Shi JX, Su X, Xu J, Zhang WY, Shi Y. 2012. HuR post-transcriptionally regulates TNF-α-induced IL-6 expression in human pulmonary microvascular endothelial cells mainly via tristetraprolin. Respir. Physiol. Neurobiol. 181:154-161.
29. Sternberg SH, Haurwitz RE, Doudna JA. 2012. Mechanism of substrate selection by a highly specific CRISPR endoribonuclease. RNA 18:661-672.
30. Zhang J, Bowden GT. 2008. UVB irradiation regulates Cox-2 mRNA stability throughAMPKandHuRin human keratinocytes. Mol. Carcinog. 47:974-983.
31. Kuwano Y, Kim HH, Abdelmohsen K, Pullmann R, Martindale JL, Yang X, Gorospe M. 2008. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol. Cell. Biol. 28:4562-4575.
32. Fan XC, Steitz JA. 1998. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. U. S. A. 95:15293-15298.
33. Loflin P, Chen CY, Shyu AB. 1999. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13:1884-1897.
34. Covarrubias S, Richner JM, Clyde K, Lee YJ, Glaunsinger BA. 2009. Host shutoff is a conserved phenotype of gammaherpesvirus infection and is orchestrated exclusively from the cytoplasm. J. Virol. 83:9554-9566.
35. Clyde K, Glaunsinger BA. 2011. Deep sequencing reveals direct targets of gammaherpesvirus-induced mRNA decay and suggests that multiple mechanisms govern cellular transcript escape. PLoS One 6:e19655. doi:10 .1371/journal.pone.0019655.
36. Chen CY, Shyu AB. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
37. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A. 1986. Identification of a common nucleotide sequence in the 3=-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. U. S. A. 83:1670-1674.
38. Gratacós FM, Brewer G. 2010. The role of AUF1 in regulated mRNA decay. Wiley Interdiscip. Rev. RNA 1:457-473.
39. Guhaniyogi J, Brewer G. 2001. Regulation of mRNA stability in mammalian cells. Gene 265:11-23.
40. Dempsey LA, Hanakahi LA, Maizels N. 1998. A specific isoform of hnRNP D interacts with DNA in the LR1 heterodimer: canonical RNA binding motifs in a sequence-specific duplexDNAbinding protein. J. Biol. Chem. 273:29224-29229.
41. Wagner BJ, DeMaria CT, Sun Y, Wilson GM, Brewer G. 1998. Structure and genomic organization of the human AUF1 gene: alternative premRNA splicing generates four protein isoforms. Genomics 48:195-202.
42. Brennan CM, Steitz JA. 2001. HuR and mRNA stability. Cell. Mol. Life Sci. 58:266-277.
43. Rozovics JM, Chase AJ, Cathcart AL, Chou W, Gershon PD, Palusa S, Wilusz J, Semler BL. 2012. Picornavirus modification of a host mRNA decay protein. mBio 3:e00431-12. doi:10.1128/mBio.00431-12.
44. Sokoloski KJ, Dickson AM, Chaskey EL, Garneau NL, Wilusz CJ, Wilusz J. 2010. Sindbis virus usurps the cellular HuR protein to stabilize its transcripts and promote productive infections in mammalian and mosquito cells. Cell Host Microbe 8:196-207.
45. Spångberg K, Wiklund L, Schwartz S. 2000. HuR, a protein implicated in oncogene and growth factormRNAdecay, binds to the 3= ends of hepatitis C virus RNA of both polarities. Virology 274:378-390.
46. Harris D, Zhang Z, Chaubey B, Pandey VN. 2006. Identification of cellular factors associated with the 3=-nontranslated region of the hepatitis C virus genome. Mol. Cell. Proteomics 5:1006-1018.
47. Korf M, Jarczak D, Beger C, Manns MP, Krüger M. 2005. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. J. Hepatol. 43:225-234.
48. Corcoran JA, Khaperskyy DA, Johnston BP, King CA, Cyr DP, Olsthoorn AV, McCormick C. 2012. Kaposi"s sarcoma-associated herpesvirus G-protein-coupled receptor prevents AU-rich-element-mediated mRNA decay. J. Virol. 86:8859-8871.
49. Iliopoulos D, Hirsch HA, Struhl K. 2009. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139:693-706.
50. Semaan N, Frenzel L, Alsaleh G, Suffert G, Gottenberg JE, Sibilia J, Pfeffer S, Wachsmann D. 2011. miR-346 controls release of TNF-α protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization. PLoS One 6:e19827. doi:10.1371/journal.pone.0019827.
51. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
52. Jones MR, Quinton LJ, Blahna MT, Neilson JR, Fu S, Ivanov AR, Wolf DA, Mizgerd JP. 2009. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat. Cell Biol. 11:1157-1163.
53. Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, Zheng ZM. 2011. Kaposi"s sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J. Virol. 85:2620-2630.
54. Lee YJ, Glaunsinger BA. 2009. Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction. PLoS Biol. 7:e1000107. doi:10.1371/journal/pbio.1000107.
55. Lee HY, Haurwitz RE, Apffel A, Zhou K, Smart B, Wenger CD, Laderman S, Bruhn L, Doudna JA. Investigating RNA-protein interaction networks using a conditional CRISPR nuclease. Proc. Natl. Acad. Sci. U. S. A., in press.